Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman, M.D., will become Recursion’s Chief Medical Officer ...
In March 2026, Citeline announced an expanded strategic partnership with Recursion Pharmaceuticals to integrate Citeline's real-world data and evidence into Recursion’s tech-enabled drug discovery and ...
Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (NASDAQ: RXRX), a leading tech-bio company decoding biology ...
9d
Goldman is betting Nvidia will get a boost from health care as industry builds out AI capabilities
Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost its shares, per Goldman Sachs.
Event driven snapshot of Recursion Pharmaceuticals Recursion Pharmaceuticals (RXRX) shares have been drawing attention after ...
There is something almost disarmingly sincere about youth orchestras; an openness of gesture, a lack of defensive irony, that ...
New programming expands hospitality model and diversifies revenue streams amid shifting direct-to-consumer landscape. April 1 ...
Evotec SE (NASDAQ:EVO) Q4 2025 Earnings Call Transcript April 8, 2026 Evotec SE reports earnings inline with expectations. Reported EPS is $0.2098 EPS, expectations were $0.2098. Operator: Ladies and ...
Silicon Valley’s timeline for "solving" human health is dangerously optimistic, but AI is quietly breaking pharma’s biggest ...
Logan Graham, the leader of the red team, recalled the bioweapons scare as an example of the challenges Anthropic faces at a ...
Arka Mazumder hails from a middle-class family and had to also take education loans. Now, however, with a lucrative job, he ...
Faculty members at Northeast Community College are beginning to integrate artificial intelligence tools into their classrooms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results